de maria marchiano, ruggero
 Distribuzione geografica
Continente #
NA - Nord America 296
EU - Europa 153
AS - Asia 69
AF - Africa 2
Totale 520
Nazione #
US - Stati Uniti d'America 293
IT - Italia 82
SG - Singapore 29
SE - Svezia 27
CN - Cina 18
IN - India 14
FI - Finlandia 10
DE - Germania 9
IE - Irlanda 6
ID - Indonesia 5
GB - Regno Unito 4
FR - Francia 3
NL - Olanda 3
AL - Albania 2
HK - Hong Kong 2
MX - Messico 2
RU - Federazione Russa 2
TG - Togo 2
BG - Bulgaria 1
CA - Canada 1
CH - Svizzera 1
DK - Danimarca 1
IL - Israele 1
LT - Lituania 1
RO - Romania 1
Totale 520
Città #
Fairfield 61
Rome 29
Singapore 25
Cambridge 22
Houston 21
Chandler 20
Woodbridge 20
Seattle 19
Ashburn 16
Santa Clara 16
Helsinki 9
San Paolo di Civitate 9
Wilmington 7
Ann Arbor 6
Lawrence 6
Milan 6
Princeton 6
San Diego 6
Florence 5
Jakarta 5
Norwalk 5
Andover 4
Beijing 4
Dearborn 4
Dublin 4
Plano 4
Sacramento 4
Lucera 3
Millbury 3
Turin 3
Boardman 2
Bovisio-Masciago 2
Bremen 2
Falkenstein 2
Hamburg 2
Hong Kong 2
Latina 2
Lomé 2
Mexico City 2
New York 2
Paris 2
Phoenix 2
Amsterdam 1
Boston 1
Cadelbosco di Sopra 1
Durrës 1
Fuzhou 1
Grafing 1
Guidonia 1
Guiyang 1
Harbin 1
Hebei 1
Lappeenranta 1
Levallois-perret 1
London 1
Los Angeles 1
Lucknow 1
Marano di Napoli 1
Menlo Park 1
Messina 1
Moscow 1
Nanjing 1
Palermo 1
Quzhou 1
Sofia 1
Southend 1
Suzhou 1
Tel Aviv 1
Torino 1
Toronto 1
Xian 1
Zhengzhou 1
Totale 406
Nome #
Distinct HR expression patterns significantly affect the clinical behavior of metastatic HER2+ breast cancer and degree of benefit from novel anti-HER2 agents in the real world setting 100
"Triple positive" early breast cancer: an observational multicenter retrospective analysis of outcome 86
Therapeutic potential of combined BRAF/MEK blockade in BRAF-wild type preclinical tumor models 77
HSP90 inhibition alters the chemotherapy-driven rearrangement of the oncogenic secretome 76
KEAP1 and TP53 frame genomic, evolutionary and immunological subtypes of lung adenocarcinoma with different sensitivity to immunotherapy 62
Replication stress response in cancer stem cells as a target for chemotherapy 53
Type I IFNs promote cancer cell stemness by triggering the epigenetic regulator KDM1B 37
Lung Cancer Organoids. The Rough Path to Personalized Medicine 36
Uracil- and Pyridine-containing HDAC inhibitors displayed cytotoxicity in colorectal and glioblastoma cancer stem cells 33
Transcriptional phenocopies of deleterious KEAP1 mutations correlate with survival outcomes in lung cancer treated with immunotherapy 10
null 4
Concise Review: Gene of The Month {KEAP}1-mutant non-small cell lung cancer: the catastrophic failure of a cell-protecting hub 2
Totale 576
Categoria #
all - tutte 1.800
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.800


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202091 0 0 0 0 0 15 19 19 14 12 8 4
2020/202133 10 3 3 2 1 1 0 0 3 9 0 1
2021/202284 0 3 7 5 24 3 3 5 2 4 21 7
2022/202398 17 23 4 9 10 7 9 7 7 1 4 0
2023/202478 5 8 4 3 3 7 8 8 1 7 11 13
2024/2025114 8 14 13 24 39 16 0 0 0 0 0 0
Totale 576